However, the risk allele substantially enhances TFAP2A DNA binding, consistent with a model in which the rs1264326 daSNV enhances TFAP2A promoter binding to alter expression of DDR1 and PSORS1C1 pro-inflammatory genes and drive risk for acne rosacea. The gene discussed is TFAP2A; the disease is rosacea.